Li Kang Biomedical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	82.04	77.02	110.99	112.09	51.44	69.27
Depreciation & Amortization	9.8	12.43	11.74	10.99	12.89	15.02
Loss (Gain) From Sale of Assets	-	-	-	-	-	-0.01
Loss (Gain) From Sale of Investments	0.33	-0.28	-0.9	2.2	1.75	1.11
Stock-Based Compensation	-	4.64	-	-	-	-
Other Operating Activities	-4.33	-29.45	-5.4	13.2	-8.71	0.72
Change in Accounts Receivable	-1.36	-0.25	0.92	-2.15	-0.59	-2.54
Change in Inventory	-10.91	-3.66	-8.79	-4.25	2.64	-2.11
Change in Accounts Payable	4.89	4.57	-8	3.76	8.18	-2.32
Change in Other Net Operating Assets	-10.07	0.35	-3.82	21.41	-7.16	2.53
Operating Cash Flow	70.39	65.38	96.74	157.24	60.45	81.67
Operating Cash Flow Growth	-13.15%	-32.42%	-38.48%	160.14%	-25.98%	-11.77%
Capital Expenditures	-317.46	-62.75	-3.26	-1.16	-4.25	-1.77
Sale of Property, Plant & Equipment	-	-	-	-	-	0.01
Sale (Purchase) of Intangibles	-0.16	-1.98	-	-1.54	-0.2	-0.11
Investment in Securities	247.46	-199.54	-62.01	-58.33	14.44	-72.15
Other Investing Activities	5.72	6.5	3.43	1.41	2.21	0.94
Investing Cash Flow	-64.44	-257.76	-61.84	-59.62	12.2	-73.07
Short-Term Debt Issued	-	24	12	-	-	-
Long-Term Debt Issued	-	35	35	-	-	-
Total Debt Issued	119.55	59	47	-	-	-
Short-Term Debt Repaid	-	-24	-12	-	-	-
Long-Term Debt Repaid	-	-35	-43.48	-33.47	-7.52	-8.2
Total Debt Repaid	-36.98	-59	-55.48	-33.47	-7.52	-8.2
Net Debt Issued (Repaid)	82.57	-	-8.48	-33.47	-7.52	-8.2
Issuance of Common Stock	-	225	-	-	-	-
Common Dividends Paid	-63.61	-79.52	-46.62	-33.3	-62.16	-44.4
Other Financing Activities	-	-	0.02	-0.2	0.29	-
Financing Cash Flow	18.96	145.48	-55.07	-66.97	-69.39	-52.6
Net Cash Flow	24.91	-46.9	-20.17	30.65	3.26	-44.01
Free Cash Flow	-247.06	2.63	93.48	156.08	56.19	79.9
Free Cash Flow Growth	-	-97.19%	-40.11%	177.77%	-29.67%	-13.54%
Free Cash Flow Margin	-42.48%	0.46%	14.85%	22.81%	14.52%	17.49%
Free Cash Flow Per Share	-7.73	0.08	3.47	5.79	2.09	2.96
Cash Interest Paid	-	0.25	0.62	0.32	0.42	0.55
Cash Income Tax Paid	18.11	43.33	28.53	12.06	17.79	16.15
Levered Free Cash Flow	-203.07	-13.73	70.08	127.73	40.35	60.46
Unlevered Free Cash Flow	-202.96	-13.3	70.47	127.91	40.64	60.8
Change in Working Capital	-17.45	1.02	-19.69	18.76	3.07	-4.44

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.